TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genscript Biotech ( (HK:1548) ) has shared an update.
Legend Biotech, an associate of Genscript Biotech, announced that its product CARVYKTI® generated approximately $439 million in net trade sales for the quarter ending June 30, 2025. This financial performance is linked to a collaboration with Janssen Biotech, highlighting the product’s market success and potential impact on Genscript’s financial standing and industry positioning.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotechnology industry. The company is associated with Legend Biotech Corporation, which is involved in the development of pharmaceutical products and is listed on the Nasdaq Global Select Market in the U.S.
Average Trading Volume: 24,957,436
Technical Sentiment Signal: Buy
Current Market Cap: HK$32.93B
Learn more about 1548 stock on TipRanks’ Stock Analysis page.